President, Plasma-Derived Therapies Business Unit at Takeda & Chair of the Global Executive Board at PPTA
Today we recognize the estimated 400 million people globally living with a rare disease. We know there is much work ahead to address unmet medical needs of these patients and that means securing a timely diagnosis, effectively treating their symptoms, but also improving their lives as a whole. So important that innovations emerge to help people with rare diseases live better, enabling greater autonomy and more quality time with the people they love, doing activities that bring them joy. Many patients with rare, chronic and complex diseases such as primary immunodeficiencies depend on plasma-derived therapies, requiring frequent and life-long treatment. With therapeutic advances such as subcutaneous immunoglobulin treatment, those patients now have the option to self-administer at home, which can already contribute substantially to improving their lives. We need to continue investing as an industry to shorten infusion time and ease overall burden of IG administration, whilst developing more holistic digital solutions that help patients better manage their disease and treatment. This #RareDiseaseDay, it’s important for the healthcare ecosystem to consider the whole patient, focusing both on transformative therapies to change the treatment paradigm for the future, but also meeting patients where they are today with innovations to improve their treatment experience. #RareDiseaseDay #Plasma #PlasmaDerivedTherapies #Innovation
Giles , Very Nicely Articulated as Always & Provoking the Health Care Industry to Chanelise the Resources ( Intellectual & Financial) towards Innovation of Early Diagnosis ,Treatment & Access Across the Globe. Creating CONTINUED AWARENESS IS EQUALLY IMPORTANT.
Very well said Giles! - and also WELL DONE!! There is, of course, a long way to go, globally. However, with your Takeda team and others of like mind showing the way, a successful outcome will surely be achieved. 👍👍👍
SVP- Global Head of BioLife Plasma Services at Takeda
5moI couldn't agree more! I'm proud to be part of an organization that is committed to developing transformative solutions for patients with rare diseases. I'm also grateful for the plasma donors and BioLife team members who help to make treatments for certain rare disorders possible, and helping to bring better health and a brighter future to patients globally.